Clinical Characterization, Prognostic, and Predictive Values of HER2-low in Patients with Early Breast Cancer in the PALLAS Trial (Abcsg-42/Aft-05/big-14–13/pre0109)
BREAST CANCER RESEARCH（2024）
Key words
Breast cancer,HER2-low,Palbociclib,Endocrine therapy,Antibody–drug conjugates
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined